Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

☰

Dropping Revenue: Expect More Cuts and Closures as LabCorp Aligns Covance Biz

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-job-cuts.jpg" NAME"Dropping Revenue: Expect More Cuts and Closures as LabCorp Aligns Covance Biz" ALT"Dropping Revenue: Expect More Cuts and Closures as LabCorp Aligns Covance Biz"April 26, 2017By Mark Terry,…

Continue ReadingDropping Revenue: Expect More Cuts and Closures as LabCorp Aligns Covance Biz

Some Predict Biogen???s Alzheimer???s Drug Will Fail

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x470-biogen.jpg" NAME"Some Predict Biogens Alzheimers Drug Will Fail" ALT"Some Predict Biogens Alzheimers Drug Will Fail"April 26, 2017By Mark Terry, BioSpace.com Breaking News StaffThe predominant theory in Alzheimer... Source: BioSpace

Continue ReadingSome Predict Biogen???s Alzheimer???s Drug Will Fail

Why High-Flying M&A Target Tesaro Recently Lost More Than a Quarter of Its Value

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks2.jpg" NAME"Why High-Flying M&A Target Tesaro Recently Lost More Than a Quarter of Its Value" ALT"Why High-Flying M&A Target Tesaro Recently Lost More Than a Quarter of Its Value"April…

Continue ReadingWhy High-Flying M&A Target Tesaro Recently Lost More Than a Quarter of Its Value